COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2393-9079

Online ISSN:-2393-9087


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 662

Emailed: 0

PDF Downloaded: 235

Indian Journal of Pharmacy and Pharmacology

Evaluation of anxiolytic activity of rousvastatin in male albino mice

Full Text PDF Share on Facebook Share on Twitter

Author Details : Avanthi E, Pradeep Kumar L

Volume : 4, Issue : 1, Year : 2017

Article Page : 5-7

Suggest article by email


Objectives: To assess the anxiolytic activity of ROUSVASTATIN in male albino mice. To compare the anxiolytic activity of ROUSVASTATIN with standard drug as diazepam.
Materials and Methods: The study was conducted in Pharmacology Dept., JJM medical college. Rousvastatin and Diazepam were dissolved in saline. Control group mice were injected with saline. Drugs and saline were injected intraperitoneally.
Results: In elevated plus maze Rousvastatin at dose 30 mg/kg and 50mg/kg increased number of open arm and total arm entries, time spent in open arm and decreased time spent in closed arm.
Conclusion: The results suggest that the significant dose-dependent antianxiety activity of Rousvastatin is similar to the behavioural effects of Diazepam.

Anxiolytic activity, Rousvastatin, Diazepam

How to cite : Avanthi E, Pradeep Kumar L, Evaluation of anxiolytic activity of rousvastatin in male albino mice. Indian J Pharm Pharmacol 2017;4(1):5-7

Copyright © 2017 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (